The World Bank has added $8 billion more for Covid-19 vaccines, totalling $20 billion, for developing countries. Earlier it had announced $12 billion.
The funding will be available through 2022, it said in a statement on Wednesday.
"In view of the surging demand for World Bank vaccine finance, I am pleased to announce today that the World Bank is expanding its financing available for Covid-19 vaccine financing to $20 billion over the next 18 months, adding $8 billion to the previously announced $12 billion," said David Malpass, World Bank Group President David Malpass, in the statement.
Malpass also called on countries with surplus doses to release it for use by developing countries, and for vaccine manufacturers to prioritise the available doses for the developing countries that so urgently need them.
On Wednesday, the bank's private financing arm the International Finance Corporation secured a 600 million euro package for a South African vaccine manufacturer to ramp up production of Covid-19 treatment therapies and vaccines in the African continent.
Further, the Bank also provided over $4 billion for the purchase and deployment of Covid vaccines for 51 developing countries, half of which are in Africa.
Since the start of the Covid pandemic, the World Bank Group has approved more than $150 billion to fight the health, economic, and social impacts of the pandemic.
Since April 2020, the Bank has scaled up its financing by over 50 per cent, helping more than 100 countries meet emergency health needs, strengthen pandemic preparedness, while also supporting countries as they protect the poor and jobs, and jump-starting a climate-friendly recovery.
Malpass also confirmed the deal with Johnson & Johnson for 400 million doses for Africans
"The World Bank now is helping developing countries in every region of the world with vaccine purchase and rollouts, including efforts to boost supply, enhance transparency, accelerate deployment, and match available doses with country needs," Malpass said.
"Significant challenges still remain regarding vaccine deployment and hesitancy. We are taking action on all fronts to tackle these challenges, working in solidarity with international and regional partners to expedite doses to as many people as possible and to enhance disease surveillance, preparedness, and response," added Axel van Trotsenburg, World Bank Managing Director of Operations.
--IANS
rvt/in
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU